Skip to main content
. 2021 Nov 15;2021(11):CD009286. doi: 10.1002/14651858.CD009286.pub4

Li 2008.

Study characteristics
Methods Parallel trial, 3 (fluoxetine versus "free and easy wandering" versus placebo), we are using the fluoxetine versus placebo comparison in this review
Participants Country: China
Setting: unclear
Stroke criteria: by neuroimaging, ischaemic or PICH
Depression diagnosis: "each patient was evaluated by a psychiatrist", HAMD > 20 included
Fluoxetine group: 60 people, mean age 69.2 ± 3.5 years, men 41.6%
Control: 30 people, mean age 67.8 ± 3.9 years, men 56.7%
Excluded psychiatric illness other than depression, antidepressants within previous 2 weeks, MMSE < 23, severe aphasia
Interventions Treatment: fluoxetine 20 to 40 mg daily
Control: placebo
Duration of treatment: 8 weeks
Duration of follow‐up (treatment end to study end): 0
Outcomes HAMD
BI
Description of why participants left the trial early
AEs (reported by participant or observed/elicited by physician at each visit)
Funding source Funded by the Natural Science Foundation of Shandong Province, People's Republic of China. None of authors had financial ties with the companies producing the medications in this study
Notes Note twice as many in fluoxetine as in control group
Study conducted between March 2006 to September 2007. None of the authors or departments involved in the study had financial ties with the companies producing the medications used in this study
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated random numbers
Allocation concealment (selection bias) Unclear risk Unclear
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Paper states blinded, used placebo (though unclear if matching, thus unclear (had a matching placebo been used then it would have been low)
Blinding of outcome assessment (detection bias)
All outcomes Low risk Blinded
Incomplete outcome data (attrition bias)
All outcomes Unclear risk 4/90 dropped out (< 5%)
Selective reporting (reporting bias) Unclear risk No protocol
Other bias Low risk Balanced baseline